Biogen Reports First Quarter 2017 Revenues of $2.8 Billion

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Biogen Reports First Quarter 2017 Revenues of $2.8 Billion

Biogen (BIIB) PT Raised to $280 at Stifel

April 25, 2017 11:18 AM EDT

Stifel analyst Thomas Shrader raised his price target on Biogen (NASDAQ: BIIB) to $280.00 (from $265.00) while maintaining a Hold rating following results this morning.

The analyst noted the results were positive for the companys goal to trim some of the fat from... More

Biogen (BIIB) Tops Q1 EPS by 20c

April 25, 2017 7:00 AM EDT

Biogen (NASDAQ: BIIB) reported Q1 EPS of $5.20, $0.20 better than the analyst estimate of $5.00. Revenue for the quarter came in at $2.8 billion versus the consensus estimate of $2.74 billion.

Total revenues of $2.8 billion, a 3% increase versus the prior year and an 8% increase excluding hemophilia... More